CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-07-17 | KUMAR AMIT Director | Purchase | +1,000 | $5.40 | $5K | 92,408 |
| 2015-07-17 | Titterton Lewis H jr Director | Purchase | +3,000 | $5.44 | $16K | 477,040 |
| 2015-07-17 | JOHNSON BRUCE F Director | Purchase | +8,400 | $5.45 | $46K | 383,987 |
| 2015-07-10 | BERMAN ROBERT ANDREW President and CEO | Purchase | +200 | $4.00 | $800 | 40,558 |
Page 21 of 21 · 404 trades